Company Press Releases

Released Company Title Topic Industry Provider
27 Jun 2019 07:00 CET PROBIODRUG Vivoryon Therapeutics AG: Vivoryon Therapeutics AG enters myeloid immune checkpoint drug discovery, and collaborates with the University of Kiel to select cancer therapy candidates from its QPCTL inhibitor portfolio Alliances and agreements Biotechnology EQS Group
18 Jun 2019 07:00 CET PROBIODRUG Vivoryon Therapeutics AG: Vivoryon Therapeutics mandates goetzpartners as strategic business development advisor for expansion of its innovative QPCTL technology into immuno-oncology Alliances and agreements Biotechnology EQS Group
12 Jun 2019 07:00 CET PROBIODRUG Probiodrug AG becomes Vivoryon Therapeutics AG Change in Capital Biotechnology EQS Group
29 May 2019 18:00 CET PROBIODRUG Probiodrug AG: Ordinary General Meeting of Shareholders of Probiodrug AG General meeting / Board Meeting Biotechnology EQS Group
22 May 2019 07:00 CET PROBIODRUG Probiodrug to attend International Conferences in June 2019 Other subject Biotechnology EQS Group
16 May 2019 07:00 CET PROBIODRUG Probiodrug AG: Probiodrug Reports First Quarter 2019 Business Update Commercial results Biotechnology EQS Group
09 May 2019 07:00 CET PROBIODRUG Probiodrug AG: Probiodrug AG to Publish its First Quarter 2019 Business Update on May 16, 2019 Other subject Biotechnology EQS Group
18 Apr 2019 15:06 CET PROBIODRUG Probiodrug AG: Probiodrug AG to hold its Ordinary General Meeting of Shareholders on 29 May 2019 General meeting / Board Meeting Biotechnology EQS Group
15 Apr 2019 07:00 CET PROBIODRUG Probiodrug AG: Probiodrug raises EUR 8.2 million in successful private placement of new shares Change in Capital Biotechnology EQS Group
09 Apr 2019 18:09 CET PROBIODRUG Probiodrug AG: Probiodrug raises EUR 8.2 million from investors in successful private placement of new shares Change in Capital Biotechnology EQS Group
04 Apr 2019 07:00 CET PROBIODRUG Probiodrug AG: Probiodrug AG has mandated ODDO SEYDLER BANK AG as Designated Sponsor Other subject Biotechnology EQS Group
28 Mar 2019 07:00 CET PROBIODRUG Probiodrug AG: Probiodrug reports full year 2018 financial results Commercial results Biotechnology EQS Group
21 Mar 2019 07:00 CET PROBIODRUG Probiodrug AG: Probiodrug AG to Publish its Full Year 2018 Results on March 28, 2019 Other subject Biotechnology EQS Group
21 Mar 2019 07:00 CET PROBIODRUG Probiodrug AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] Other subject Biotechnology EQS Group
20 Mar 2019 07:00 CET PROBIODRUG Probiodrug AG: Probiodrug and Alzheimer's Disease Cooperative Study (ADCS) Receive 15 Million USD National Institutes of Health (NIH) Grant for U.S. Phase 2b Core Program for PQ912 Other subject Biotechnology EQS Group
12 Mar 2019 07:00 CET PROBIODRUG Probiodrug to attend BIO Europe Spring in March 2019 Other subject Biotechnology EQS Group
05 Feb 2019 07:00 CET PROBIODRUG Probiodrug AG: Probiodrug to attend International Conferences in February 2019 Other subject Biotechnology EQS Group
29 Nov 2018 07:04 CET PROBIODRUG Probiodrug Reports Third Quarter 2018 Business Update Commercial results Biotechnology EQS Group
23 Aug 2018 07:00 CET PROBIODRUG Probiodrug AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] Other subject Biotechnology EQS Group